Back to today’s briefing

Story perspectives

India Bans Opioid Exports Amid Escalating Crisis

2/28/2025

47 8

Summary

Story summary

In a decisive move to combat the escalating opioid crisis, India has banned the manufacture and export of tapentadol and carisoprodol. This action follows a BBC investigation that uncovered illegal exports to West Africa. Authorities seized over 1.3 crore tablets from Aveo Pharmaceuticals, which acknowledged the drugs' dangers while prioritizing profit. The government is determined to halt this troubling trend.

History

Historical Context

India's ban on tapentadol and carisoprodol reflects a growing global response to the opioid crisis, reminiscent of past drug regulation efforts. In the early 2000s, the U.S. faced similar challenges with opioid misuse, leading to stricter controls and the establishment of the Controlled Substances Act. This historical context underscores the urgent need for effective measures to combat drug-related harms.

1 of 2

Story summary

In a decisive move to combat the escalating opioid crisis, India has banned the manufacture and export of tapentadol and carisoprodol. This action follows a BBC investigation that uncovered illegal exports to West Africa. Authorities seized over 1.3 crore tablets from Aveo Pharmaceuticals, which acknowledged the drugs' dangers while prioritizing profit. The government is determined to halt this troubling trend.

1 / 2